High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India.
NAFLD
NASH
fatty liver
hepatic steatosis
metabolic syndrome
non‐alcoholic steatohepatitis
Journal
JGH open : an open access journal of gastroenterology and hepatology
ISSN: 2397-9070
Titre abrégé: JGH Open
Pays: Australia
ID NLM: 101730833
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
19
08
2018
revised:
27
10
2018
accepted:
03
11
2018
entrez:
8
5
2019
pubmed:
8
5
2019
medline:
8
5
2019
Statut:
epublish
Résumé
There is limited data on the community prevalence of non-alcoholic fatty liver disease (NAFLD). The present study evaluated the prevalence of NAFLD in a large number of healthy male blood donors of urban north India. In a prospective study performed over 18 months, voluntary blood donors fulfilling the requisite blood donation criteria and consenting to participate in the study were evaluated. The study received the approval of the institute's ethics committee. Diagnosis of NAFLD was made by excluding significant alcohol intake, ultrasound showing hepatic steatosis, and exclusion of transfusion associated infections. Subjects were also evaluated for various metabolic risk factors and the presence of metabolic syndrome. Of 1388 subjects who consented for participation, 386 did not come for evaluation. Three females, nine (0.9%) HBsAg-positive, and four (0.4%) anti-HCV positive subjects were excluded. Of the 986 males evaluated with hepatobiliary ultrasound, 543(55.1%) had fatty liver on ultrasonography [15 (1.5%) alcoholic fatty liver and 528 (53.5%) NAFLD]. Among those with NAFLD, 469 (88.8%), 54 (10.2%), and 5 (0.9%) had mild, moderate, and severe hepatic steatosis, respectively. Subjects with NAFLD, when compared to those without NAFLD, had significantly higher age, BMI, waist circumference, blood pressure, total cholesterol and triglycerides, low-density lipoprotein, and fasting plasma glucose. Multivariate regression analysis demonstrated age, BMI, waist circumference, systolic blood pressure, total cholesterol, and number of metabolic syndrome criteria as independent predictors of NAFLD. Urban Indian healthy male blood donors have a high prevalence of NAFLD.
Sections du résumé
BACKGROUND
BACKGROUND
There is limited data on the community prevalence of non-alcoholic fatty liver disease (NAFLD). The present study evaluated the prevalence of NAFLD in a large number of healthy male blood donors of urban north India.
METHODOLOGY
METHODS
In a prospective study performed over 18 months, voluntary blood donors fulfilling the requisite blood donation criteria and consenting to participate in the study were evaluated. The study received the approval of the institute's ethics committee. Diagnosis of NAFLD was made by excluding significant alcohol intake, ultrasound showing hepatic steatosis, and exclusion of transfusion associated infections. Subjects were also evaluated for various metabolic risk factors and the presence of metabolic syndrome.
RESULTS
RESULTS
Of 1388 subjects who consented for participation, 386 did not come for evaluation. Three females, nine (0.9%) HBsAg-positive, and four (0.4%) anti-HCV positive subjects were excluded. Of the 986 males evaluated with hepatobiliary ultrasound, 543(55.1%) had fatty liver on ultrasonography [15 (1.5%) alcoholic fatty liver and 528 (53.5%) NAFLD]. Among those with NAFLD, 469 (88.8%), 54 (10.2%), and 5 (0.9%) had mild, moderate, and severe hepatic steatosis, respectively. Subjects with NAFLD, when compared to those without NAFLD, had significantly higher age, BMI, waist circumference, blood pressure, total cholesterol and triglycerides, low-density lipoprotein, and fasting plasma glucose. Multivariate regression analysis demonstrated age, BMI, waist circumference, systolic blood pressure, total cholesterol, and number of metabolic syndrome criteria as independent predictors of NAFLD.
CONCLUSIONS
CONCLUSIONS
Urban Indian healthy male blood donors have a high prevalence of NAFLD.
Identifiants
pubmed: 31061888
doi: 10.1002/jgh3.12117
pii: JGH312117
pmc: PMC6487825
doi:
Types de publication
Journal Article
Langues
eng
Pagination
133-139Références
J Assoc Physicians India. 2000 Mar;48(3):311-3
pubmed: 11229116
Indian J Gastroenterol. 2001 Sep-Oct;20(5):183-6
pubmed: 11676329
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Hepatology. 2003 Apr;37(4):917-23
pubmed: 12668987
J Gastroenterol Hepatol. 2004 Apr;19(4):368-74
pubmed: 15012772
Trop Gastroenterol. 2004 Apr-Jun;25(2):76-9
pubmed: 15471321
Hepatology. 2004 Dec;40(6):1387-95
pubmed: 15565570
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18273-7
pubmed: 17114290
World J Gastroenterol. 2007 Jan 28;13(4):649-50
pubmed: 17278239
Dig Dis Sci. 2007 Sep;52(9):2368-74
pubmed: 17420951
Indian J Med Res. 2007 Mar;125(3):345-54
pubmed: 17496360
Hepatology. 2007 Nov;46(5):1387-91
pubmed: 17685472
Ann Hepatol. 2007 Jul-Sep;6(3):161-3
pubmed: 17786142
Dig Dis Sci. 2008 Jul;53(7):1967-76
pubmed: 18030620
Diabetes Res Clin Pract. 2009 Apr;84(1):84-91
pubmed: 19168251
Hepatology. 2010 May;51(5):1593-602
pubmed: 20222092
Hepatology. 2010 Dec;52(6):2248-9
pubmed: 20725907
PLoS One. 2011;6(9):e24362
pubmed: 21949711
Gastroenterology. 2012 Jun;142(7):1592-609
pubmed: 22656328
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
J Clin Exp Hepatol. 2015 Mar;5(1):51-68
pubmed: 25941433
Hepatol Int. 2013 Jun;7(2):548-54
pubmed: 26201786
Hepatol Int. 2013 Dec;7 Suppl 2:755-64
pubmed: 26202291
Hepatol Int. 2014 Jan;8(1):121-7
pubmed: 26202413
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
J Gastroenterol Hepatol. 2018 Jan;33(1):70-85
pubmed: 28670712
Br Med J (Clin Res Ed). 1986 Jan 4;292(6512):13-5
pubmed: 3080046